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Abstract: Background: Essential oils (EOs) have shown antimicrobial, antioxidant,
and antiproliferative activity, which may, alone or in combination with other substances, potentially
be used for the development of new drugs. However, their chemical variability, depending on the
species, varieties, or geographical origin (among other factors) determines different bioactivities
that need to be evaluated. Methods: The antioxidant activity of Corymbia citriodora and eight
Eucalyptus species EOs was determined using two different methods: the scavenging ability of
2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS+•) and peroxyl free radicals or oxygen
radical absorbance capacity (ORAC). Antibacterial activity was evaluated using the microorganisms
Streptococcus pneumoniae (strains D39 and TIGR4), and Haemophilus influenza (strain DSM 9999).
The essential oils’ minimum inhibitory concentration (MIC) and minimum bactericidal concentration
(MBC) was assessed using a microdilution method. The antiproliferative activity was determined using
the THP-1 cell line (human acute monocytic leukaemia) with methylthiazolyldiphenyl-tetrazolium
bromide assay (MTT). Results: Corymbia citriodora and Eucalyptus viminalis EOs showed the highest
ABTS and peroxyl free radical scavenging capacity. Eucalyptus globulus EO showed a high potential to
treat Streptococcus pneumoniae infections. Haemophilus influenzae was the respiratory pathogen that
showed the highest resistance to all EOs, including tea tree EO. After 96 h of incubation, at 25 µg/mL,
Eucalyptus radiata and Eucalyptus viminalis EOs showed highest cytotoxic activity against the THP-1
cell line. Conclusions: Despite their specific bioactivities, no single EO showed simultaneously good
antioxidant, antimicrobial, and antiproliferative activity.
Keywords: Corymbia citriodora; Eucalyptus dives; Eucalyptus globulus; Eucalyptus delegatensis subsp.
tasmaniensis; Eucalyptus pauciflora; Eucalyptus radiata; Eucalyptus smithii; Eucalyptus urophylla;
Eucalyptus viminalis
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1. Introduction
Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae may asymptomatically
colonize the upper respiratory tract and are the etiologic agents of acute otitis media, sinusitis,
and pneumonia. S. pneumoniae is also responsible for bacterial meningitis [1,2]. Nowadays,
the treatment of these diseases is threatened by the development of antibiotic resistance worldwide [3].
Essential oils (EOs) and their isolated compounds have been shown to possess antimicrobial activity
against several pathogens [4]. The complex mixtures that generally constitute EOs can be advantageous
because pathogens have difficulty in displaying resistance mechanisms to the multiple constituents of
essential oils [5,6].
Reactive oxygen species (ROS) have a physiological role in normal cell function, but when their
production exceeds their elimination, an excess of ROS in the body occurs and consequently, diseases
also arise because ROS can damage important biomolecules [7]. Damage of nucleic acids may trigger
cancer development. In general, it is considered that the use of antioxidants prevents or retards the
appearance of diverse diseases, including cancer, although le Gal et al. [8] reported that increased
intracellular antioxidant activity may induce tumour cell survival. EOs have been demonstrated to
possess antioxidant and antiproliferative properties which may contribute to the development of new
chemotherapeutic drugs in the future [9].
The Myrtaceae eucalyptus group comprises four genera: Angophora Cav., Arillastrum (Brongniart &
Gris) Pancher ex Baillon, Corymbia K. D. Hill & L.A.S. Johnson, and Eucalyptus L’Herit [10,11]. Despite
this classification, it is common to designate as Eucalyptus several species of the four genera [12].
The eucalyptus group includes around 900 species and subspecies (Brooker and Kleinig in [13]).
Species of the genus Eucalyptus are well adapted to diverse edaphoclimatic conditions, show rapid
growth, and are easy to cultivate. Hence the genus Eucalyptus, originally from Australia, is widespread
all over the world. Eucalyptus is mainly cultivated for obtaining cellulose, wood, gum, and EOs.
The latter is obtained from the leaves and used in medicine, perfumery, and the food industry [14].
The recent compilation by Dhakad et al. [15] shows that Eucalyptus spp. leaf EOs possess
biological and pharmacological properties, namely antimicrobial, antidiabetic, anthelmintic, antiviral,
antihistaminic, anti-inflammatory, antimalarial, antioxidant, cytotoxic, larvicidal, nerve blocking,
and pain-relieving activity, and are also useful for the relief of respiratory diseases and for wound
healing. Eucalyptus EOs also possess activities as insecticides, pesticides, and nematicides [15–17].
Eucalyptus leaf essential oils are usually dominated by monoterpenes and sesquiterpenes.
Nevertheless, their relative amounts or the ratio between them may differ according to species and
varieties. Even within the same variety, the chemical composition may change depending on the
geographical origin [12]. This highlights the importance of the knowledge of chemical composition
since it will determine the bioactivity of each EO.
In the present work, the antioxidant, antimicrobial, and antiproliferative activities of EOs from
Corymbia citriodora, Eucalyptus dives, Eucalyptus globulus, Eucalyptus delegatensis subsp. tasmaniensis,
Eucalyptus pauciflora, Eucalyptus radiata, Eucalyptus smithii, Eucalyptus urophylla, and Eucalyptus viminalis
(all from Portugal) were evaluated.
2. Materials and Methods
2.1. Plant Material, EO Extraction, and Composition Analysis
EOs were isolated from fresh aerial parts, collected during the vegetative phase in Portugal
(Table 1), and their composition determined as previously described [18].
2.1.1. Isolation of the Essential Oils
The essential oils were isolated by hydrodistillation for 3 h using a Clevenger-type apparatus
according to the European Pharmacopoeia method [19]. The isolation procedure was run at a
distillation rate of 3 mL/min, and the essential oils were stored at −20 ◦C in the dark until analysis.
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2.1.2. Gas Chromatography (GC)
Gas chromatographic analyses were performed using a Perkin Elmer Autosystem XL gas
chromatograph (Perkin Elmer, Shelton, CT, USA) equipped with two flame ionization detectors
(FIDs), a data handling system, and a vaporizing injector port into which two columns of different
polarities were installed: a DB-1 fused-silica column (100% dimethylpolysiloxane, 30 m × 0.25 mm i.d.,
film thickness 0.25 µm; J & W Scientific Inc., Folsom, CA, USA) and a DB-17HT fused-silica column
((50%-phenyl)-methylpolysiloxane, 30 m × 0.25 mm i.d., film thickness 0.15 µm; J & W Scientific
Inc.). The oven temperature was programmed to 45–175 ◦C, increasing at 3 ◦C/min, subsequently
increased to 300 ◦C at to 15 ◦C/min, and then maintained isothermal for 10 min; injector and detector
temperatures were 280 ◦C and 300 ◦C, respectively. The carrier gas, hydrogen, was adjusted to a linear
velocity of 30 cm/s. The samples were injected using a split sampling technique, ratio 1:50. The volume
of injection was 0.1 µL of a distilled n-pentane-oil solution (1:1). The percentage composition of the
oils was computed by the normalization method from the GC peak areas, calculated as a mean value
of two injections from each oil, without response factors.
2.1.3. Gas Chromatography-Mass Spectrometry (GC-MS)
The GC-MS unit consisted of a Perkin Elmer Autosystem XL gas chromatograph, equipped
with DB-1 fused-silica column (30 m × 0.25 mm i.d., film thickness 0.25 µm; J & W Scientific,
Inc.), and interfaced with Perkin-Elmer Turbomass mass spectrometer (software version 5.4.2.1617,
PerkinElmer, Shelton, CT, USA). Injector and oven temperatures were as above; transfer line
temperature, 280 ◦C; ion source temperature, 220 ◦C; carrier gas, helium, adjusted to a linear velocity
of 30 cm/s; split ratio, 1:40; ionization energy, 70 eV; scan range, 40–300 u; scan time, 1 s. The identity
of the components was assigned by comparison of their retention indices, relative to C9-C17 n-alkane
indices, and GC-MS spectra from a laboratory-made library based upon the analyses of reference oils,
laboratory-synthesized components, and commercial available standards.
2.2. Determination of Antioxidant Activity
Antioxidant activity was determined with 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)
(ABTS+•) free radical scavenging activity and oxygen radical absorbance capacity (ORAC) methods.
For the ABTS method, the preformed radical monocation of ABTS+• was generated by dissolving
ABTS in water (7 mM), adding potassium persulfate (2.45 mM, final concentration), and allowing the
mixture to stand overnight in the dark at room temperature. Before the assay, the ABTS+• solution
was diluted with ethanol to obtain a solution with absorbance of 0.70 at 734 nm [20]. For the assay,
10 µL of sample were added to 1000 µL of ABTS+• solution and left to stand for 6 min, after which
the absorbance was read spectrophotometrically at 734 nm. For the control, the volume of sample
was replaced by ethanol. The antioxidant activity of each sample was calculated as scavenging effect
% (IA%, Inhibitory Activity Percentage) = [(A0 − A1)/A0] × 100, where A0 is the absorbance of the
control, and A1 is the absorbance of the sample. The same procedure was repeated using diverse
concentrations of Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) [21]. The values
obtained with the samples were compared with the curve for several Trolox concentrations and the
final results given as µmol Trolox equivalent (TE)/g EOs. Tests were carried out in triplicate.
For the ORAC assay, fluorescein (FL) was used as fluorescent probe [22]. Briefly, in each well
150 µL of fluorescein working solution and 25 µL of the previously diluted sample, blank (75 mM
phosphate buffer), or standard (Trolox) were added. The plate was covered with a lid and incubated
in the preheated (37 ◦C) BioTek SynergyTM 4 Hybrid Microplate Reader (BioTek, Swindon, UK) for
10 min after shaking for 3 min. Then 2,2′-Azobis-2-methyl-propanimidamide dihydrochloride (AAPH)
was added to each well of the plate, except for the control and blank wells. The final volume of the
assay was 200 µL. The fluorescence was read every minute for 90 min at 485 nm excitation and 527 nm
emissions. ORAC values were calculated according to [23]. Briefly, the net area under the curve
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(AUC) of the standard (Trolox) and samples was calculated. The standard curve was obtained by
plotting Trolox concentrations against the average net AUC of the measurements for each concentration.
Final ORAC values were calculated using the regression equation between Trolox concentration and
the net AUC and were expressed as µmol TE/g EO [24]. Tests were carried out in triplicate.
2.3. Determination of Antibacterial Activity
Antibacterial activity was determined against two strains of Streptococcus pneumoniae D39
and TIGR4, and Haemophilus influenza DSM 9999. Bacterial strains were kept at −70 ◦C in brain
heart infusion (BHI) (Oxoid) supplemented with glycerol (final concentration 25%, v/v) until use.
The cultures were recovered from freezing by growth in brain heart infusion supplemented with
5% (v/v) horse blood at 37 ◦C in microaerophilic conditions. Prior to the assay bacterial cultures
were grown in Columbia agar (Oxoid) plates supplemented with 5% (v/v) horse blood at 37 ◦C in
microaerophilic conditions for 24 h. From this plate a suspension with a turbidity value corresponding
to 0.5 in the McFarland scale was prepared. From this suspension 0.1 mL was transferred to a new
Columbia agar plate supplemented with 5% (v/v) horse blood. Sterile filter paper discs of 6 mm (Oxoid)
were distributed on the agar surface and 3 µL of each essential oil was dispensed in the paper discs.
Tea tree essential oil with 38% terpinen-4-ol (Optima Healthcare Ltd., Bradford, UK) was included as
reference. Sterile n-propanol (essential oil solvent) and the antibiotic chloramphenicol (30 µg/disk)
were used as control. Inhibition zones were evaluated after 24 h at 37 ◦C in microaerophilic conditions.
The assays were done in triplicate.
The minimum inhibitory concentration (MIC) for the tested EOs was determined using a
microdilution method [6,25]. Concentrations ranging from 0 to 0.4 mg/mL with increments of
0.05 mg/mL were tested. Three replicates for each bacterium were used. The recovery of the viability
of each bacterium was evaluated, and the minimum concentration at which no viability was observed
was considered as the minimum bactericidal concentration (MBC).
2.4. Determination of Antiproliferative Activity
Human leukaemic cell line THP-1 cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% (v/v) foetal bovine serum, 1% (v/v) nonessential amino acids,
100U/mL penicillin, and 100 µg/mL streptomycin, according to [24]. They were incubated at 37 ◦C in
a humidified 5% CO2 atmosphere.
The growth inhibitory effect of EOs was measured using the 3-(4,5-dimethylthiazol-2-yl)
2,5-diphenyltetrazolium bromide (MTT) assay [26]. THP-1 cells were seeded in 96-well plate at
5 × 103 cells/well and submitted to different EO concentrations (10–500 µg/mL). All samples were
dissolved in dimethyl-sulfoxide (DMSO). The solvent concentration in the incubation medium never
exceeded 0.5%. Control cultures had the equivalent concentration of DMSO. After treatment, cells were
incubated (1 h) in the usual culture conditions after addition of the same volume of medium containing
MTT (2 mg/mL). After this period, 150 µL HCl (0.1 M) in isopropanol was added to dissolve the blue
formazan crystals formed owing to the reduction of MTT. Absorbance at 570 nm using a background
reference wavelength of 630 nm was measured. Antiproliferative activity was expressed as the mean
absorbance values for the negative control (DMSO-treated cells) standardized as 100% absorbance
(i.e., no growth inhibition) and results were expressed as absorbance (% of control) versus essential oil
concentration [24].
2.5. Statistical Analysis
Data were analysed by one-way analysis of variance (ANOVA) using IBM SPSS Statistics version
23 (IBM, Armonk, NY, USA). Tukey’s test was used to determine the difference at 5% significance level.
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Table 1. Studied Corymbia and Eucalyptus species. Currently accepted scientific names for plant species, arranged in alphabetic order of the corresponding plant family,
sampling year, plant part used for hydrodistillation, plant source, essential oil yield, and main essential oil components (≥10%).
Family/Species Code SY PP CP Yield (%, v/w) Main Components (≥10%) *
Myrtaceae
Current accepted species name Synonyms
Corymbia citriodora (Hook.) K.D.Hill &
L.A.S.Johnson a
Corymbia citriodora subsp. variegata (F.Muell.) A.R.Bean &
M.W.McDonald, Corymbia variegata (F.Muell.) K.D.Hill &
L.A.S.Johnson, Eucalyptus citriodora Hook., Eucalyptus maculata
var. citriodora (Hook.) F.M.Bailey, Eucalyptus melissiodora Lindl.,
Eucalyptus variegata F.Muell.
Cc 2009 FV MEE 0.86 citronellal 36, isopulegol 13,citronellol 12, 1,8-cineole 11
Eucalyptus dives Schauer a Eucalyptus amygdalina var. latifolia H.Deane & Maiden Ed 2009 FV MEE 3.30 piperitone 40, α-phellandrene 19,p-cymene 19
Eucalyptus globulus Labill. b
Eucalyptus gigantea Dehnh., Eucalyptus glauca A.Cunn. ex DC.,
Eucalyptus globulosus St.-Lag., Eucalyptus globulus subsp.
globulus, Eucalyptus maidenii subsp. globulus (Labill.) J.B.Kirkp.,
Eucalyptus perfoliata Desf., Eucalyptus pulverulenta Link
Eg 2009 FV Lisbon 2.15 1.8-Cineole 64, α-pinene 20
Eucalyptus delegatensis subsp.
tasmaniensis Boland c
Eucalyptus gigantea Hook.f., Eucalyptus risdonii var. elata Benth.,
Eucalyptus tasmanica Blakely Edt 2011 FV MEE 0.52
Limonene 36, p-cymene 11,
1,8-cineole 10
Eucalyptus pauciflora Sieber ex Spreng a
Eucalyptus coriacea A.Cunn. ex Schauer, Eucalyptus coriacea var.
alpina Benth, Eucalyptus pauciflora var. alpina Ewart, Eucalyptus
pauciflora subsp. pauciflora, Eucalyptus phlebophylla F.Muell. ex
Miq., Eucalyptus submultiplinervis Miq., Eucalyptus sylvicultrix
F.Muell. ex Benth.
Ep 2009 FV MEE 0.84 α-pinene 82
Eucalyptus radiata A.Cunn. ex DC. a
Eucalyptus amygdalina var. radiata (A.Cunn. ex DC.) Benth.,
Eucalyptus australiana R.T.Baker & H.G.Sm., Eucalyptus
australiana var. latifolia R.T.Baker & H.G.Sm., Eucalyptus
phellandra R.T.Baker & H.G.Sm., Eucalyptus radiata var.
australiana (R.T.Baker & H.G.Sm.) Blakel, Eucalyptus radiata
subsp. radiata, Eucalyptus radiata var. subexserta Blakely
Er 2009 FV MEE 5.55 1,8-cineole 48, p-cymene 13
Eucalyptus smithii R.T. Baker a Eucalyptus viminalis var. pedicellaris H.Deane & Maiden Es 2009 FV MEE 2.80 1,8-cineole 83
Eucalyptus urophylla S. T. Blake a No synonyms recorded Eu 2009 FV MEE 0.86 α-phellandrene 45, 1,8-cineole 23
Eucalyptus viminalis Labill. a
Eucalyptus angustifolia Desf. ex Link, Eucalyptus gunnii Miq.,
Eucalyptus huberiana Naudin, Eucalyptus viminalis var. huberiana
(Naudin) N.T.Burb., Eucalyptus viminalis var. rhynchocorys
Maiden, Eucalyptus viminalis subsp. viminalis
Ev 2009 FV MEE 1.10 1,8-cineole 46, α-pinene 13,
γ-terpinene 12
SY: Sampling year, PP: Plant part, CP: Collection place. * Essential oils previously isolated and chemically characterized in a Faria et al. [18], b Barbosa et al. [17] and c Sena et al. [27]
(detailed composition of this EO in Supplementary Table S1). FV–fresh, vegetative-phase aerial parts, MEE: Mata Experimental do Escaroupim arboretum (Salvaterra de Magos, Portugal).
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3. Results and Discussion
3.1. Antioxidant Activity
The antioxidant activity of the EO was determined with an electron reaction-based method
(the ABTS+ method) and a hydrogen reaction-based method (the ORAC method). With the TEAC
method, Cc EO showed significantly higher antioxidant activity (5.08 µmol TE/g EO) than Eucalyptus
EOs (Table 2). The lowest antioxidant activity was observed with Eg, Ep, Er and Es EOs, without
significant differences among them. The activities ranged from 0.10 in Es to 0.30 µmol TE/g in Eg EO.
Cc EO showed the highest scavenging peroxyl radical activity (148.55 µmol TE/g EO) along with Ev
EO (135.80 µmol TE/g EO) (Table 2). Eu EO (37.14 µmol TE/g EO) showed the lowest peroxyl radical
scavenging activity.
Results for the essential oils of Cc and Es are in agreement with those previously reported by
Luis et al. [28] for these species. In Luis et al. [28] study, citronellal (78%) was the main component for
Corymbia citriodora EO, and 1,8-cineole (82%) dominated in Eucalyptus smithii EO.
Citronellal shows moderate antioxidant activity due to its limited capacity to scavenge free
radicals [29]. The antioxidant activity of citronellal may be related to one unpaired electron from the
molecule allylic hydrogen of both CH3 or CH2 (Figure 1) that by resonance stabilize the radical formed
after the reaction. Nevertheless, Wojtunik et al. [30] considered that only the presence of conjugation
of pi bonds would allow a resonance-stabilized structure. However, essential oils are complex mixtures
and the antioxidant activity cannot be assigned to only one compound. The different constituents
of EOs may act synergistically or antagonistically, leading to an overall activity that results from the
interaction among several compounds. Ciesla et al. [29] studied the capacity of binary mixtures of
some common EO terpenoids, for scavenging DPPH free radicals. They reported an antagonistic effect
between citronellal and 1,8-cineole, both present in Cc EO. Nonetheless, the interaction of citronellal
with other constituents could trigger a synergistic effect, responsible for the high level of activity
observed in Cc EO. Antagonism was also observed by Ciesla et al. [29] for the binary mixture of
1,8-cineole and p-cymene. These constituents were the major Er EO compounds (Table 1). Eg, Ep,
Er, and Es EOs, which showed the lowest free radical scavenger activities, had 1,8-cineole, α-pinene,
and p-cymene as major constituents. These monoterpenes were previously reported as poor scavengers
of DPPH free radicals [31]. γ-Terpinene, one of the main constituents of Ev EO, is considered a good free
radical scavenger [29,32], possibly due to the delocalization of the unpaired electron along the molecule,
owing to the two allylic hydrogens that can stabilize the resonance-structures (Figure 1). Moreover,
the binary mixture of γ-terpinene and 1,8-cineole (another major constituent of Ev EO) did not produce
any significant effects. Despite the presence of an allylic hydrogen in p-cymene in conjugation with
an aromatic ring, its abstraction from the molecule can be difficult due to steric hindrances, because
hydrogen is hidden by the two CH3 groups as well as by the aromatic ring (Figure 1).
Table 2. The activity of essential oils of Corymbia citriodora and Eucalyptus spp. for scavenging ABTS+
and peroxyl radicals.
Sample Code * TEAC (µmol TE/g Essential Oil) ORAC (µmol TE/g Essential Oil)
Cc 5.08 ± 0.08 a 148.55 ± 7.76 a
Ed 0.53 ± 0.08 d 96.83 ± 7.76 bc
Edt 1.27 ± 0.08 c 73.31 ± 7.76 c
Eg 0.30 ± 0.08 e 87.29 ± 7.76 bc
Ep 0.17 ± 0.08 e 99.70 ± 7.76 b
Er 0.21 ± 0.08 e 112.33 ± 7.76 b
Es 0.10 ± 0.08 e 93.66 ± 7.76 bc
Eu 0.68 ± 0.08 d 37.14 ± 7.76 d
Ev 1.62 ± 0.08 b 135.80 ± 7.76 a
* For sample code see Table 1. Values in the same column followed by the same letter are not significant by Tukey’s
multiple range test (p < 0.05).
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3.2. Antibacterial Activity
Essential oils of thyme, tea tree, peppermint, anise, fennel, and eucalyptus may be used
for the treatment of simple respiratory tract diseases [4]. Eucalyptus EOs have been used in the
treatment of bronchitis, cold, cough, and in the symptomatic relief of catarrh of the upper respiratory
tract [4]. Tea tree EO has been used for treating some respiratory infections, such as bronchitis, cold,
and influenza [4].
S. pneumoniae, H. influenzae, and Staphylococcus aureus have been associated with
community-acquired pneumonia, along with the less common Pseudomonas aeruginosa, Pneumocystis
jirovecii, Moraxella catarrhalis, and other Gram-negative bacteria [33].
In the present work the capacity for inhibiting the growth of two strains of S. pneumoniae (D39 and
TIGR4) and H. influenzae (DSM 9999) by Cc, Ed, Eg, Es and Ev EOs was evaluated and compared with
that of tea tree EO and the antibiotic chloramphenicol (Table 3).
Table 3. The antibacterial activities of Corymbia citriodora and Eucalyptus spp. EOs expressed as
inhibition zones, in mm. Tea tree oil and chloramphenicol were used as references.
Essential Oil
Microorganism †
S. pneumoniae D39 S. pneumoniae TIGR 4 H. influenza DSM 9999
Tea tree 14.00 ± 1.73 a 12.25 ± 1.89 a 11.75 ± 2.36 a
C. citriodora 11.33 ± 2.03 a 8.00 ± 1.41 b 11.25 ± 0.50 a
E. dives 13.67 ± 2.08 a NI 10.00 ± 0.81 a
E. globulus 12.00 ± 1.73 a 8.75 ± 0.95 b 13.00 ± 1.82 a
E. smithii 14.00 ± 1.73 a 8.00 ± 0.81 b 12.00 ± 2.16 a
E. viminalis 14.66 ± 1.52 a 6.66 ± 0.57 b 11.75 ± 1.50 a
Chloramphenicol 22.33 ± 4.04 b 21.00 ± 1.15 c 24.00 ± 0.81 b
† Data represent the mean ± standard deviation of three replicates. Data with the same superscript letter are not
significantly different (p > 0.05). NI: No inhibition.
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All essential oils showed poor antibacterial activity in comparison with the antibiotic
chloramphenicol, however differences could be observed among the EOs and bacterial strains (Table 3).
For example, all EOs were less effective against S. pneumoniae TIGR4 in comparison with S. pneumoniae
D39. For S. pneumoniae TIGR 4, tea tree EO showed better activity than Myrtaceae EOs, and the strain
was even resistant to Ed EO. For H. influenzae, no significant differences (p > 0.05) were observed
between the antibacterial activity-assayed Myrtaceae EOs (Table 3).
The MIC and MBC values were determined for Es, Eg, and tea tree EOs (Table 4). The lowest
MIC and MBC values were observed for Eg EO against S. pneumoniae TIGR 4, with values of 0.015
and 0.05 mg/mL, respectively. Both S. pneumoniae strains showed a similar MIC and MBC for the
tea tree EO, namely 0.025 and 0.1 mg/mL, respectively. However, for the Es EO S. pneumoniae D39
showed a similar MIC value to S. pneumoniae TIGR 4, but the MBC value was the double of that of
S. pneumoniae TIGR 4, showing an MBC of 0.3 mg/mL in contrast to TIGR 4 that showed an MBC
of 0.15 mg/mL (Table 4). Such differences may be associated with serotype differences between
the strains. Moreover, Eg EO, that in the diffusion agar test showed a very weak activity against
S. pneumoniae TIGR 4, displayed an efficient activity in the microdilution assay, even in comparison
with tea tree EO. These differences may be related to its low diffusion ability. Intriguing was the
resistant behaviour of H. influenza that was able to growth at the highest EO concentration tested
(0.4 mg/mL). Eg EO showed a better activity against S. pneumoniae, that can be related with its richness
in 1,8-cineole and α-pinene. In addition, 1,8-cineole prevents the growth of other microorganisms,
but when in association with other terpenes in an essential oil, such as camphene, α-pinene, globulol
and limonene, it was more efficient against S. aureus, methicillin-resistant S. aureus (MRSA), Escherichia
coli and Candida albicans, and also biofilms of MRSA and P. aeruginosa [34].
Table 4. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)
values for Eucalyptus and tea tree EOs §.
Microorganism
Tea Tree E. globulus E. smithii
MIC † MBC † MIC MBC MIC MBC
S. pneumoniae D39 0.025 0.1 0.1 0.15 0.1 0.30
S. pneumoniae TIGR 4 0.025 0.1 0.015 0.05 0.1 0.15
H. influenza DSM 9999 >0.4 >0.4 >0.4 >0.4 >0.4 >0.4
§ Data represent the mean of three independent experiments. † mg/mL.
3.3. Antiproliferative Activity
The antiproliferative activities of Corymbia and Eucalyptus species EOs were studied with the
THP-1 cell line (human acute monocytic leukaemia) using the MTT assay. Cells were incubated to
increasing amounts of EOs for 24 h and 96 h (Figures 2 and 3).
EOs decreased viability of THP-1 cells in a dose-dependent manner. After one day, a great
difference was observed between the antiproliferative activity of Eg and Es EOs and the other
EOs, particularly at 50 µg/mL. Hence, Eg and Es EOs possessed the lowest antiproliferative
activities. After 96 h incubation of THP1 cells with EOs, the differences were more evident
for lower concentrations (10 and 25 µg/mL). At 25 µg/mL, it was possible to distinguish two
EOs (Er and Ev) with significantly higher antiproliferative activity than the remaining EOs.
At 50 µg/mL, these differences disappeared, because almost all EOs showed survival percentages
<20%. The exceptions were Eg and Es EOs, that showed survival percentages above >70%, at 50 µg/mL.
The main constituents of Eg EO were 1,8-cineole (64%) and α-pinene (20%), and in Es EO, 1,8-cineole
represented 80% of the total EO (Table 1). The major components of the Er and Ev EOs also included
1,8-cineole (48 and 46%, respectively), and other components such as p-cymene (13%) for Er and
α-pinene (20%), and γ-terpinene (12%) for Ev EOs (Table 1). The results suggested that 1,8-cineole has
low antiproliferative activity on the THP-1 leukaemia cell line, although in the presence of p-cymene
or γ-terpinene, the antiproliferative activity increased.
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The weak antiproliferative activity of 1,8-cineole, p-cymene, α-pinene has been reported [35],
despite these monoterpenes having not been assayed together. Results may suggest a potential
synergistic effect between the following pairs: 1,8-cineole and p-cymene, and 1,8-cineole with
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4. Conclusions
The highest scavenging of ABTS+ and peroxyl free radicals was obs rved in Cc and Ev EOs,
and the lowest was detected in Eu EO. All essential oils were less effective against S. pneumoniae TIGR4
than again t th D39 train. IC and BC values showed that Eg EO is promising for the treatment of
S. pneumoniae infections. EOs displayed low diffusion capacity and the antibacterial activity screening
through microdilution test would be more appropriate. H. influenzae was the respiratory pathogen that
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showed the highest resistance to all EOs including that of tea tree. Eg and Es EOs showed the lowest
antiproliferative activities on THP-1 cells. After 96 h incubation, the Er and Ev EOs showed the highest
antiproliferative activity against THP-1 cells. Although further assays are required, the results suggest
that the antiproliferative activity is challenged by the combination of 1,8-cineole with p-cymene or
with γ-terpinene. Despite their specific bioactivities, none of the assayed EOs showed simultaneously
good antibacterial, antioxidant, and antiproliferative capacity.
Supplementary Materials: The following are available online at www.mdpi.com/2305-6320/5/3/61/s1, Table S1:
Percentage composition of the essential oil isolated from Eucalyptus delegatensis subsp. tasmaniensis Boland,
previously included in the study of Sena et al. [27] under the former name of E. gigantea.
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